Innovation, Access to Medicines & Global Governance (GHP 554)
This graduate-level course will explore policy issues related to health technology innovation and access to medicines in developing countries. In particular it will address the global governance challenges related to securing access to existing medicines while also promoting innovation of new medicines for the specific health needs of developing countries. It will look at the importance of innovation and access to medicines for achieving better global health and the role that global governance in a broad sense plays in facilitating and preventing achievement of these goals; the challenges of fostering research, development and innovation in medicines and health technologies in the discovery and development phases for diseases that primarily affect the world¿s poor (e.g., lack of markets/incentives, lack of capacity); barriers to providing access to medicines for people around the world at the delivery stage (e.g., intellectual property protections, trade regimes, corruption, counterfeiting, regulatory processes, health systems capacity, markets); and the role that international institutions and other actors can play in responding to these challenges (i.e., intellectual property reform, pooled funding mechanisms, incentives, information and accountability). Students will also review various proposals for reform and global efforts to address this challenge. This course will focus on international and global factors and will to a lesser extent address national pharmaceutical polices in developing countries. The course will be in a seminar format with active involvement of students through case study discussions and simulations. Students will learn about current policy processes and understand how countries are negotiating reforms in this field of global health.